Categories AlphaGraphs, Earnings, Other Industries

Plug Power Q2 revenue surges 75%

Hydrogen fuel cell maker Plug Power Inc (PLUG) reported a 75% increase in its second-quarter revenue to $39.9 million, in line with the guidance set by the company. The company reported a narrower net loss of $25.8 million or $0.12 per share, compared to the year-over period. On an adjusted basis, loss per share was $0.08, in line with analysts estimates.

For Q3 2018, the company expects sales to be about of $47 million to $52 million. The company forecasts a range for positive adjusted gross margin of 9% to 12% and EBITDAS of negative $3 million to break even. For the full year 2018, Plug Power anticipates revenues to total $155 million to $180 million.

During the Q2 2018, the company shipped a total of 1,102 GenDrive units compared to 830 units in the prior-year period. Six GenFuel sites were installed in the quarter versus four in the prior-year period. Plug Power had 67 sites under fuel delivery contract on June 30, 2018, versus 46 sites on June 30, 2017

PLUG POWER EARNINGS Q2 2018

Free cash flow for the second quarter of 2018 was negative $20.4 million compared to negative $43.4 million in the second quarter of 2017. As of June 30, 2018, Plug Power had a total cash position of $55.4 million, including cash and cash equivalents of $15.0 million and restricted cash of $40.4 million.

The company’s priority remains being an EBITDAS-breakeven business in the second half of 2018 as well as one that is positioned to be cash flow and EBITDAS positive from next year.

Related Infographic

Plug Power first quarter 2018 earnings

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top